Kyle T. Elligers

Family Medicine
374 Grand Ave
New Haven, CT 06513

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer.

First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer.

Journal: Cancer chemotherapy and pharmacology
Published: June 23, 2013
Showing 1-1 of 1

Last Updated: 09/26/2026